Case Study Suggests Even Low-Dose Risperdal Side Effects May Cause Tardive Dyskinesia Movement Disorders
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Risperdal Lawsuit Ends in $1B Verdict Against Johnson & Johnson April 12, 2012 Staff Writers Add Your Comments Johnson & Johnson has been hit with a $1.2 billion verdict by an Arkansas judge, after a jury found the company guilty of hiding or minimizing the health risks associated with their antipsychotic Risperdal. Arkansas Circuit Court Judge Tim Fox decided on a fine of $1.19 billion for 240,000 violations of Arkansas Medicaid fraud laws. The company was also fined $11 million for deceptive practices. The decision is the latest in a string of losses for Johnson & Johnson as a result of lawsuits brought by various states over the drug maker’s illegal marketing of Risperdal for off-label uses and failure to adequately disclose the side effects Risperdal. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION In January, Johnson & Johnson agreed to pay the Department of Justice (DOJ) more than $1 billion to settle federal claims of illegal marketing. Off-label marketing occurs when a drug company promotes the use of its drug for purposes other than those approved by the FDA, and is illegal. Doctors can prescribe a drug for any purpose they see fit, but companies cannot promote them for unapproved uses. The DOJ has been investigating Johnson & Johnson’s marketing of Risperdal since 2004, when it began looking into an alleged kickback scheme between the drug maker and Omnicare, the nation’s largest provider of drugs to nursing homes. In 2009, Omnicare reached a settlement with DOJ over kickback charges. The DOJ investigators indicated that Johnson & Johnson paid Omnicare millions to push off-label use of Risperdal to nursing home doctors and hid the kickbacks as data fees, education fees and payments to attend Omnicare meetings. In January 2010, the DOJ filed a civil False Claims Act complaint against J&J. Risperdal is frequently used as a “chemical restraint” in nursing homes, used to subdue unruly residents. However, studies have shown that the drug increases the risk of death in patients with dementia, and there have been nationwide efforts to curb its use for such off-label purposes. Tags: Antipsychotics, Arkansas, Dementia, Johnson & Johnson, Nursing Home, Risperdal More Risperdal Lawsuit Stories Court Considers Remanding Risperdal Breast Cancer Lawsuit to California State Court October 29, 2025 Case Study Suggests Even Low-Dose Risperdal Side Effects May Cause Tardive Dyskinesia Movement Disorders December 14, 2022 Breast Cancer Side Effects Linked to Antipsychotic Medications: Study December 9, 2021 3 Comments Nereida August 20, 2012 I do have a new pituitary gland tumour after 7 months of Risperdal, while I was nursing my baby with breast milk. It was said to me by the Doc that the drug was harmless for the baby, because it was a very little amount that will pass out by the breast milk. Now I have a Pituitary Gland tumour, and and issue in the pancreas that I could not do yet the magnetic resonance of the pancreas, to see what is the mass that has been found in the ecography. Please, help me with this I opened a facebook webpage, Afectados en Venezuela por Risperdal, also a twitter account @afctdxrisperdal, please press the “I like it” in the facebook web page and share it with all the people you can, to help me. Also follow my twitter address, and share it around the world. I beg you. I need to fight this against Johnson & Johnson from Venezuela, it is not the same as to be in USA. I have 37, I have Bipolar disorder, it was prescribed t me because of that, I am a single mom, with a daughter of 4 years and another of 2. I NEED YOUR HELP to share my webpage and twitter all around the wolrd. Thanks angela April 15, 2012 Agree 110%with Daniel. My grandson is 9 years old, has been prescribed multiple pysch meds, the pyschiatrist don’t want anyone questioning them. My grandson has been repeatedly hospitalized since November with Pancreititis, including NOW. And no one wants to say it has anything to do with these meds. I am in the process of completing research Daniel April 13, 2012 Risperdal reproached. Same saga here as Eli Lilly Zyprexa. Johnson and Johnson is a trusted brand we associate with babies. Risperdal,Zyprexa,as well as the other atypical antipsychotics, are being prescribed for children, even though this is an unapproved, off-label use. An estimated 2.5 million children are now taking atypical antipsychotics. Over half are being given them for Attention Deficit Hyperactivity Disorder,many of these foster children. Weight gain, increases in triglyceride levels and associated risks for (life-long) diabetes and cardiovascular disease. Eli Lilly made $65 BILLION on Zyprexa! CommentsThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court (Posted: today) Lawsuits over Ozempic and Wegovy vision loss will be consolidated for pretrial proceedings in New Jersey, separate from claims involving gastrointestinal injuries. MORE ABOUT: OZEMPIC LAWSUITJudge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues (10/28/2025)Ozempic Gastroparesis Problems Persisted After Injections Stopped, Lawsuit Alleges (10/21/2025)Ozempic, Wegovy Kidney Side Effects Highlighted in New Study (10/10/2025) GalaFLEX Breast Mesh Problems Were Highlighted in Warnings Issued by Former Becton Dickinson Medical Director (Posted: 3 days ago) Former Becton Dickinson safety officer Dr. Hooman Noorchashm warns that the company’s GalaFLEX mesh is being used off-label in breast reconstruction without FDA approval, as lawsuits investigate whether the manufacturer failed to warn about its potential risks. MORE ABOUT: BREAST MESH LAWSUITBreast Mesh Reconstruction Surgery Gaining Popularity Despite Safety Concerns, Lawsuits (11/10/2025)Internal Bra Mesh Failure Stories Highlight Risk of Pain, Infections and Other Problems (11/06/2025)Internal Bra Side Effects Raise Questions About Manufacturers’ Knowledge of Mesh Failures (10/27/2025) Hair Relaxer Lawsuit MDL Status Hearings Scheduled Throughout 2026 (Posted: 4 days ago) A series of case management conferences have been scheduled for hair relaxer litigation throughout 2026, leading up to expected bellwether trials in 2027. MORE ABOUT: HAIR RELAXER LAWSUITUpdate on Hair Relaxer Lawsuit Status To Be Provided to Court at MDL Hearing (11/05/2025)Hair Relaxer Injury Lawsuit Against L’Oreal, Strength of Nature Cleared To Move Forward (10/20/2025)MDL Judge To Weigh Hair Relaxer Cancer Evidence in Mid-2026 (09/11/2025)
Case Study Suggests Even Low-Dose Risperdal Side Effects May Cause Tardive Dyskinesia Movement Disorders December 14, 2022
Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court (Posted: today) Lawsuits over Ozempic and Wegovy vision loss will be consolidated for pretrial proceedings in New Jersey, separate from claims involving gastrointestinal injuries. MORE ABOUT: OZEMPIC LAWSUITJudge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues (10/28/2025)Ozempic Gastroparesis Problems Persisted After Injections Stopped, Lawsuit Alleges (10/21/2025)Ozempic, Wegovy Kidney Side Effects Highlighted in New Study (10/10/2025)
GalaFLEX Breast Mesh Problems Were Highlighted in Warnings Issued by Former Becton Dickinson Medical Director (Posted: 3 days ago) Former Becton Dickinson safety officer Dr. Hooman Noorchashm warns that the company’s GalaFLEX mesh is being used off-label in breast reconstruction without FDA approval, as lawsuits investigate whether the manufacturer failed to warn about its potential risks. MORE ABOUT: BREAST MESH LAWSUITBreast Mesh Reconstruction Surgery Gaining Popularity Despite Safety Concerns, Lawsuits (11/10/2025)Internal Bra Mesh Failure Stories Highlight Risk of Pain, Infections and Other Problems (11/06/2025)Internal Bra Side Effects Raise Questions About Manufacturers’ Knowledge of Mesh Failures (10/27/2025)
Hair Relaxer Lawsuit MDL Status Hearings Scheduled Throughout 2026 (Posted: 4 days ago) A series of case management conferences have been scheduled for hair relaxer litigation throughout 2026, leading up to expected bellwether trials in 2027. MORE ABOUT: HAIR RELAXER LAWSUITUpdate on Hair Relaxer Lawsuit Status To Be Provided to Court at MDL Hearing (11/05/2025)Hair Relaxer Injury Lawsuit Against L’Oreal, Strength of Nature Cleared To Move Forward (10/20/2025)MDL Judge To Weigh Hair Relaxer Cancer Evidence in Mid-2026 (09/11/2025)